Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 26, 2008
Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes
Kristina K Wolf, Kenneth R Brouwer, Gary M Pollack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 24, 2005
Modulation of hepatic canalicular or basolateral transport proteins alters hepatobiliary disposition of a model organic anion in the isolated perfused rat liver
Priyamvada Chandra, Brendan M Johnson, Peijin Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 6, 2004
Multiple transport systems mediate the hepatic uptake and biliary excretion of the metabolically stable opioid peptide [D-penicillamine2,5]enkephalin
Keith A Hoffmaster, Maciej J Zamek-Gliszczynski, Gary M Pollack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 31, 2008
Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration
Rong Zhao, J Cory Kalvass, Souzan B Yanni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 22, 2008
Relationship between drug/metabolite exposure and impairment of excretory transport function
Maciej J Zamek-Gliszczynski, J Cory Kalvass, Gary M Pollack, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 11, 2004
Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems
Keith A Hoffmaster, Maciej J Zamek-Gliszczynski, Gary M Pollack, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2007
Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data
J Cory Kalvass, Emily R Olson, Michael P Cassidy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 13, 2006
Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes
Ryan Z Turncliff, Keith A Hoffmaster, J Cory Kalvass, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 9, 2002
Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment
Hao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
March 20, 2008
Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier
Björn Bauer, Anika M S Hartz, Jonathan R Lucking, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 26, 2008
Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes
Kristina K Wolf, Kenneth R Brouwer, Gary M Pollack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 24, 2005
Modulation of hepatic canalicular or basolateral transport proteins alters hepatobiliary disposition of a model organic anion in the isolated perfused rat liver
Priyamvada Chandra, Brendan M Johnson, Peijin Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 6, 2004
Multiple transport systems mediate the hepatic uptake and biliary excretion of the metabolically stable opioid peptide [D-penicillamine2,5]enkephalin
Keith A Hoffmaster, Maciej J Zamek-Gliszczynski, Gary M Pollack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 31, 2008
Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration
Rong Zhao, J Cory Kalvass, Souzan B Yanni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 22, 2008
Relationship between drug/metabolite exposure and impairment of excretory transport function
Maciej J Zamek-Gliszczynski, J Cory Kalvass, Gary M Pollack, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 11, 2004
Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems
Keith A Hoffmaster, Maciej J Zamek-Gliszczynski, Gary M Pollack, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2007
Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data
J Cory Kalvass, Emily R Olson, Michael P Cassidy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 13, 2006
Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes
Ryan Z Turncliff, Keith A Hoffmaster, J Cory Kalvass, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 9, 2002
Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment
Hao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
March 20, 2008
Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier
Björn Bauer, Anika M S Hartz, Jonathan R Lucking, et al.
Page
of 6